This website is intended for patients and their carers

Putting the spotlight
on cholangiocarcinoma (CCA)

If you or a loved one has been diagnosed with
CCA, also called bile duct cancer, you probably
have a lot of questions. Here, you will find
information about CCA, testing and management
approaches to help you discuss next steps with
your doctor

What is cholangiocarcinoma?

Cholangiocarcinoma is cancer
that forms in the bile ducts.
Cholangiocarcinoma can also
be called CCA for short

Find out more

What are the main symptoms of CCA?

The symptoms of CCA can be hard to
recognise and are sometimes mistaken
for other conditions. For this reason,
it is difficult for doctors to diagnose CCA early

Find out more

How is CCA diagnosed?

Diagnosing CCA can be difficult.
Your doctor may need to consult with
different healthcare experts and
request different tests

Find out more

How is CCA managed?

Each case of CCA is unique.
The way your doctor manages
your cancer depends on factors like
where your tumour is located and how
far it has spread through your body
before treatment

Find out more

What questions should I ask my doctor?

You may find it useful to ask your doctor
questions to help you better understand
your diagnosis and treatment plan. Click
below to see some example questions

Find out more

This site is for EU residents 18 years of age or older. The information on this website is not a substitute for a visit or a consultation with a healthcare professional. Remember that a healthcare professional is the single best source of medical advice regarding your health. Please consult a healthcare professional if you have any questions.

By clicking third-party links, you are leaving an Incyte website and going to an external, entirely independent third-party website. Incyte provides these links as a service to its website visitors and users and takes no responsibility for any information presented on such sites or for your use of or access to such sites.

If you would like to request further medical information, please visit:
www.incyteglobalmedicalinformation.com

EU/CCA/NP/22/0006
NL/CCA/NP/22/0007
BE/CCA/NP/22/0007
Date of preparation: November 2022.

Incyte Biosciences International Sàrl
Rue Docteur-Yersin 12
1110 Morges, Switzerland

Funded and developed by Incyte Biosciences International Sàrl.

The Incyte logo is a registered trademark of Incyte.

Putting the spotlight on cholangiocarcinoma (CCA)

Putting the spotlight
on cholangiocarcinoma (CCA)